PT Kalbe Farma Tbk. (IDX:KLBF)
Indonesia · Delayed Price · Currency is IDR
1,100.00
+25.00 (2.33%)
At close: Feb 27, 2026
Revenue by Segment
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Prescription Pharmaceuticals | 9.23T | 8.22T | 6.15T | 5.72T | 4.98T | | | | | |
Prescription Pharmaceuticals Growth | 12.21% | 33.71% | 7.50% | 14.76% | -3.53% | | | | | |
| 4.31T | 4.05T | 4.15T | 3.62T | 3.38T | | | | | |
| 6.52% | -2.50% | 14.63% | 7.11% | -2.56% | | | | | |
| 8.19T | 8.37T | 7.83T | 7.17T | 6.99T | | | | | |
| -2.19% | 6.91% | 9.27% | 2.47% | 5.64% | | | | | |
Distribution and Logistic | 10.90T | 9.81T | 10.80T | 9.75T | 7.75T | | | | | |
Distribution and Logistic Growth | 11.15% | -9.21% | 10.76% | 25.80% | 5.11% | | | | | |
| 32.63T | 30.45T | 28.93T | 26.26T | 23.11T | | | | | |
| 7.16% | 5.24% | 10.18% | 13.62% | 2.12% | | | | | |
Revenue by Geography
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 30.82T | 28.56T | 27.24T | 25.01T | 22.00T | | | | | |
| 7.93% | 4.84% | 8.91% | 13.70% | 2.59% | | | | | |
| 1.80T | 1.89T | 1.69T | 1.25T | 1.11T | | | | | |
| -4.50% | 11.74% | 35.50% | 12.17% | -6.34% | | | | | |
| 32.63T | 30.45T | 28.93T | 26.26T | 23.11T | | | | | |
| 7.16% | 5.24% | 10.18% | 13.62% | 2.12% | | | | | |
Source: S&P Global Market Intelligence.